192 related articles for article (PubMed ID: 37306892)
1. Age-related decline of various cognitive functions in well-experienced male rats treated with the putative anti-aging compound (2R)-1-(1-benzofuran-2-yl)-N-propylpentane-2-amine ((-)BPAP).
Ernyey AJ; Kassai F; Kozma K; Plangár I; Somfai Z; Miklya I; Gyertyán I
Geroscience; 2024 Feb; 46(1):417-429. PubMed ID: 37306892
[TBL] [Abstract][Full Text] [Related]
2. Longevity study with low doses of selegiline/(-)-deprenyl and (2R)-1-(1-benzofuran-2-yl)-N-propylpentane-2-amine (BPAP).
Knoll J; Miklya I
Life Sci; 2016 Dec; 167():32-38. PubMed ID: 27777099
[TBL] [Abstract][Full Text] [Related]
3. Procognitive profiling of a serotonin 5-HT
Gyertyán I; Kassai F; Kozma K; Kitka T; Ernyey AJ
Brain Res Bull; 2020 Dec; 165():238-245. PubMed ID: 33086133
[TBL] [Abstract][Full Text] [Related]
4. A longevity study with enhancer substances (selegiline, BPAP) detected an unknown tumor-manifestation-suppressing regulation in rat brain.
Knoll J; Baghy K; Eckhardt S; Ferdinandy P; Garami M; Harsing LG; Hauser P; Mervai Z; Pocza T; Schaff Z; Schuler D; Miklya I
Life Sci; 2017 Aug; 182():57-64. PubMed ID: 28623006
[TBL] [Abstract][Full Text] [Related]
5. Synthetic enhancer compounds, besides acting on biogenic amine system, influence the glutamate transmission and stress response.
Knoll J; Zelena D; Timar J; Baghy K; Mervai Z; Miklya I
Behav Brain Res; 2020 Jan; 378():112290. PubMed ID: 31610214
[TBL] [Abstract][Full Text] [Related]
6. Performance of the intracerebroventricularly injected streptozotocin Alzheimer's disease model in a translationally relevant, aged and experienced rat population.
Gáspár A; Hutka B; Ernyey AJ; Tajti BT; Varga BT; Zádori ZS; Gyertyán I
Sci Rep; 2022 Nov; 12(1):20247. PubMed ID: 36424423
[TBL] [Abstract][Full Text] [Related]
7. Lack of general learning ability factor in a rat test battery measuring a wide spectrum of cognitive domains.
Kassai F; Ernyey AJ; Kozma K; Plangár I; Gyertyán I
J Integr Neurosci; 2022 Jan; 21(1):12. PubMed ID: 35164448
[No Abstract] [Full Text] [Related]
8. 1-(Benzofuran-2-yl)-2-(3,3,3-trifluoropropyl)aminopentane HCl, 3-F-BPAP, antagonizes the enhancer effect of (-)-BPAP in the shuttle box and leaves the effect of (-)-deprenyl unchanged.
Knoll J; Miklya I; Knoll B; Yasusa T; Shimazu S; Yoneda F
Life Sci; 2002 Sep; 71(17):1975-84. PubMed ID: 12175892
[TBL] [Abstract][Full Text] [Related]
9. Stimulation of the catecholaminergic and serotoninergic neurons in the rat brain by R-(-)-1-(benzofuran-2-yl)-2-propylaminopentane, (-)-BPAP.
Knoll J; Miklya I; Knoll B
Life Sci; 2002 Sep; 71(18):2137-44. PubMed ID: 12204771
[TBL] [Abstract][Full Text] [Related]
10. Effects of (R)-(-)-1-(benzofuran-2-yl)-2-propylaminopentane hydrochloride [(-)-BPAP] in animal models of mood disorders.
Tsunekawa H; Noda Y; Miyazaki M; Yoneda F; Nabeshima T; Wang D
Behav Brain Res; 2008 May; 189(1):107-16. PubMed ID: 18243357
[TBL] [Abstract][Full Text] [Related]
11. (-)-1-(Benzofuran-2-yl)-2-propylaminopentane enhances locomotor activity in rats due to its ability to induce dopamine release.
Shimazu S; Takahata K; Katsuki H; Tsunekawa H; Tanigawa A; Yoneda F; Knoll J; Akaike A
Eur J Pharmacol; 2001 Jun; 421(3):181-9. PubMed ID: 11516435
[TBL] [Abstract][Full Text] [Related]
12. TAK-915, a phosphodiesterase 2A inhibitor, ameliorates the cognitive impairment associated with aging in rodent models.
Nakashima M; Suzuki N; Shiraishi E; Iwashita H
Behav Brain Res; 2019 Dec; 376():112192. PubMed ID: 31521738
[TBL] [Abstract][Full Text] [Related]
13. The significance of selegiline/(-)-deprenyl after 50 years in research and therapy (1965-2015).
Miklya I
Mol Psychiatry; 2016 Nov; 21(11):1499-1503. PubMed ID: 27480491
[TBL] [Abstract][Full Text] [Related]
14. A tryptamine-derived catecholaminergic enhancer, (-)-1-(benzofuran-2-yl)-2-propylaminopentane [(-)-BPAP], attenuates reinstatement of methamphetamine-seeking behavior in rats.
Hiranita T; Yamamoto T; Nawata Y
Neuroscience; 2010 Jan; 165(2):300-12. PubMed ID: 19883738
[TBL] [Abstract][Full Text] [Related]
15. Learning to remember: cognitive training-induced attenuation of age-related memory decline depends on sex and cognitive demand, and can transfer to untrained cognitive domains.
Talboom JS; West SG; Engler-Chiurazzi EB; Enders CK; Crain I; Bimonte-Nelson HA
Neurobiol Aging; 2014 Dec; 35(12):2791-2802. PubMed ID: 25104561
[TBL] [Abstract][Full Text] [Related]
16. Following of aging process in a new motor skill learning model, "pot jumping" in rats.
Ernyey AJ; Grohmann Pereira T; Kozma K; Kouhnavardi S; Kassai F; Gyertyán I
Geroscience; 2019 Jun; 41(3):309-319. PubMed ID: 31129861
[TBL] [Abstract][Full Text] [Related]
17. (-)1-(Benzofuran-2-yl)-2-propylaminopentane, [(-)BPAP], a selective enhancer of the impulse propagation mediated release of catecholamines and serotonin in the brain.
Knoll J; Yoneda F; Knoll B; Ohde H; Miklya I
Br J Pharmacol; 1999 Dec; 128(8):1723-32. PubMed ID: 10588928
[TBL] [Abstract][Full Text] [Related]
18. Cognitive decline associated with normal aging in rats: a neuropsychological approach.
Zyzak DR; Otto T; Eichenbaum H; Gallagher M
Learn Mem; 1995; 2(1):1-16. PubMed ID: 10467562
[TBL] [Abstract][Full Text] [Related]
19. Antiaging compounds: (-)deprenyl (selegeline) and (-)1-(benzofuran-2-yl)-2-propylaminopentane, [(-)BPAP], a selective highly potent enhancer of the impulse propagation mediated release of catecholamine and serotonin in the brain.
Knoll J
CNS Drug Rev; 2001; 7(3):317-45. PubMed ID: 11607046
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
